Mark Leo, MD
Urology · West Warwick, RINPI 1730117730
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (50.7%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Avyxa Pharma, LLC at 31.5% of the total. 2025 is the largest year on record at $7,435, more than ten times the $13 reported in 2020. Among urology clinicians in RI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 174 payments — averaging $72.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Avyxa Pharma, LLC$4K
- Teleflex LLC$2K
- Coloplast$1K
- Procept Biorobotics Corporation$1K
- Valencia Technologies Corporation$1K
- Boston Scientific$426
- plus $3K from 27 others
What the payments were for
- Speaking & faculty fees$2,00016%
- Travel & lodging$4,08533%
- Food & beverage$6,36251%
- Education$1001%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Avyxa Pharma, LLC | 7 | $3,951 |
| Teleflex LLC | 22 | $2,015 |
| Coloplast | 20 | $1,398 |
| Procept Biorobotics Corporation | 10 | $1,031 |
| Valencia Technologies Corporation | 9 | $1,021 |
| Boston Scientific | 8 | $426 |
| Johnson & Johnson | 16 | $327 |
| Myriad Genetic Laboratories, Inc. | 6 | $277 |
| Janssen Scientific Affairs, LLC | 2 | $227 |
| Axonics, Inc. | 8 | $225 |
| Endo Pharmaceuticals Inc. | 10 | $198 |
| Immunitybio, Inc. | 2 | $168 |
| Tolmar, Inc. | 7 | $162 |
| Antares Pharma, Inc. | 8 | $156 |
| Laborie Medical Technologies Corp. | 3 | $154 |
| Endo USA, Inc. | 6 | $136 |
| AbbVie(2 entities) | 6 | $115 |
| Sumitomo Pharma America, Inc. | 4 | $85 |
| Ferring Pharmaceuticals Inc. | 3 | $74 |
| Bluewind Medical | 1 | $55 |
| Bayer | 2 | $49 |
| Dendreon Pharmaceuticals LLC | 2 | $46 |
| Pfizer | 2 | $41 |
| Blue Earth Diagnostics | 1 | $30 |
| Storz Medical America, Inc. | 1 | $28 |
| Mission Pharmacal Company | 1 | $26 |
| Bioprotect Medical, Inc. | 1 | $25 |
| Calyxo, Inc. | 1 | $19 |
| Urovant Sciences Inc | 1 | $18 |
| Myovant Sciences Inc. | 1 | $18 |
| Tolmar Pharmaceuticals, Inc. | 1 | $17 |
| Dentsply IH AB | 1 | $14 |
| Angiodynamics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UroLift$1,284
- TITAN$1,009
- AquaBeam Robotic System$833
- eCoin Device Kit$754
- Barrigel$182
- SpaceOAR VUE System - 10mL$138
- Erleada$134
- AKEEGA$134
- Balversa$134
- AMS 700$127
- ANKTIVA$110
- UroLift System$109
How this compares
$12,547 in reported general payments places this provider in the 90th percentile of 55 urology providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErleadaApalutamide | 25 | $381,760 |
| GemtesaVibegron | 48 | $39,466 |
| MyrbetriqMirabegron | 43 | $33,119 |
| Tamsulosin Hcl | 571 | $9,774 |
| Testosterone | 11 | $2,659 |
| Testosterone Cypionate | 70 | $2,403 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 57 | $1,190 |
| Methenamine Hippurate | 18 | $957 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 42 | $952 |
| Oxybutynin Chloride ErOxybutynin Chloride | 24 | $872 |
| Ciprofloxacin Hcl | 282 | $852 |
| Finasteride | 86 | $849 |
| Solifenacin Succinate | 16 | $792 |
| Ketorolac Tromethamine | 39 | $357 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 43 | $282 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonErleada | $327 | $381,76025 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $85 | $39,46648 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 55 urology providers in Rhode Island.
Other urology in West Warwick
- Joseph CambioWest Warwick$11K
- Angelo CambioWest Warwick$9K
- Alexander LubinWest Warwick$5K
- Joseph CambioWest Warwick$4K
- Atip ChatsudthipongWest Warwick$855
- Vincent CatallozziWest Warwick$666
- Dicken KoProvidence$158K
- Gyan PareekProvidence$83K
- Joseph RenzulliProvidence$81K
- Simone ThavaseelanProvidence$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.